Quality of Life: Psychological Symptoms-Effects of a 2-Month Healthy Diet and Nutraceutical Intervention; A Randomized, Open-Label Intervention Trial (RISTOMED).

Journal: Nutrients

Volume: 12

Issue: 3

Year of Publication: 2021

Affiliated Institutions:  CRMSB UMR , Université Bordeaux/CNRS, F- Bordeaux, France. Department of Experimental, Diagnostic and Specialty Medicine (DIMES), University of Bologna, Bologna, Italy. CHU Bordeaux, Pôle de gérontologie, Bordeaux, F- Bordeaux, France. Experimental Medicine Department, Sapienza University of Rome, Rome, Italy. Mendes SA, Via Giacometti - CH- Lugano, Switzerland. Department of Chemistry, University Mohammed V, BP , Rabat, Morocco. AISA (Anti-Inflammatory Senescence Actives) Therapeutics, Villejuif, France. Department Gastroenterology and Hepatology, Charité Universitätsmedizin Berlin, Berlin, Germany.

Abstract summary 

Depression symptoms and lower health-related quality of life (HRQoL) are associated with inflammation. This multicenter dietary intervention was shown to reduce inflammation in older people. This was the main outcome. Here, we describe the effects on HRQoL, anxiety, and depressive symptoms according to inflammation status. Overall, 125 healthy older subjects (65-80 year) were recruited (Italy, France, and Germany) and randomized into four arms (A, Healthy diet (HD); B, HD plus De Simone Formulation probiotic blend; C, HD plus AISA d-Limonene; D, HD plus Argan oil). The HD was weight maintaining, rich in antioxidant vitamins, polyphenols, polyunsaturated fatty acids (n6: n3 ratio = 3:1), and fiber. Data on inflammatory parameters, mental (MCS) and physical (PCS) component summaries of HRQoL (SF-36), anxiety symptoms (STAI state), and depressive symptoms (CES-D) were collected before and after 56 days of intervention. Body fat mass proportion (BFM) was considered a co-variable. A decrease of CES-D score was seen in the four arms (A: -40.0%, = 0.001; B: -32.5%, = 0.023; C: -42.8%, = 0.004; and D: -33.3%, = 0.21). Within the subgroups of subjects with medium/high inflammation a similar decrease in CES-D score occurred in all groups (A: -44.8%, = 0.021; B, -46.7%, = 0.024; C, -52.2%, = 0.039; D, -43.8%, = 0.037). The effect of interventions on CES-D was not related to baseline inflammation. MCS-HRQoL improved in A and C. There was no change in anxiety or PCS-HRQoL. In this trial with no control group, a decrease in depressive symptoms in healthy older volunteers was observed after a 2-month healthy diet intervention, independently of inflammation but with possible limitations due to participation.

Authors & Co-authors:  Bourdel-Marchasson Isabelle I Ostan Rita R Regueme Sophie C SC Pinto Alessandro A Pryen Florence F Charrouf Zoubida Z d'Alessio Patrizia P Baudron Claire Roubaud CR Guerville Florent F Durrieu Jessica J Donini Lorenzo M LM Franceschi Claudio C Valentini Luzia L

Study Outcome 

Source Link: Visit source

Statistics
Citations :  Dantzer R. Cytokine, sickness behavior, and depression. Neurol. Clin. 2006;24:441–460. doi: 10.1016/j.ncl.2006.03.003.
Authors :  13
Identifiers
Doi : 800
SSN : 2072-6643
Study Population
Male,Female
Mesh Terms
Aged
Other Terms
depressive symptoms;inflammaging;nutraceuticals;quality of life
Study Design
Randomized Control Trial
Study Approach
Country of Study
Publication Country
Switzerland